BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 36779909)

  • 1. Adult Low-Hypodiploid Acute Lymphoblastic Leukemia Evolves from TP53-Mutated Clonal Hematopoiesis.
    Saiki R; Ogawa S
    Blood Cancer Discov; 2023 Mar; 4(2):102-105. PubMed ID: 36779909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adult Low-Hypodiploid Acute Lymphoblastic Leukemia Emerges from Preleukemic TP53-Mutant Clonal Hematopoiesis.
    Kim R; Bergugnat H; Larcher L; Duchmann M; Passet M; Gachet S; Cuccuini W; Lafage-Pochitaloff M; Pastoret C; Grardel N; Asnafi V; Schäfer BW; Delabesse E; Itzykson R; Adès L; Hicheri Y; Chalandon Y; Graux C; Chevallier P; Hunault M; Leguay T; Huguet F; Lhéritier V; Dombret H; Soulier J; Rousselot P; Boissel N; Clappier E
    Blood Cancer Discov; 2023 Mar; 4(2):134-149. PubMed ID: 36630200
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Comeaux EQ; Mullighan CG
    Cold Spring Harb Perspect Med; 2017 Mar; 7(3):. PubMed ID: 28003275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute lymphoblastic leukemia with low hypodiploid/near triploid karyotype is a specific clinical entity and exhibits a very high TP53 mutation frequency of 93%.
    Mühlbacher V; Zenger M; Schnittger S; Weissmann S; Kunze F; Kohlmann A; Bellos F; Kern W; Haferlach T; Haferlach C
    Genes Chromosomes Cancer; 2014 Jun; 53(6):524-36. PubMed ID: 24619868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute Lymphoblastic Leukemia with Myeloid Mutations Is a High-Risk Disease Associated with Clonal Hematopoiesis.
    Saygin C; Zhang P; Stauber J; Aldoss I; Sperling AS; Weeks LD; Luskin MR; Knepper TC; Wanjari P; Wang P; Lager AM; Fitzpatrick C; Segal JP; Gharghabi M; Gurbuxani S; Venkataraman G; Cheng JX; Eisfelder BJ; Bohorquez O; Patel AA; Umesh Nagalakshmi S; Jayaram S; Odenike OM; Larson RA; Godley LA; Arber DA; Gibson CJ; Munshi NC; Marcucci G; Ebert BL; Greally JM; Steidl U; Lapalombella R; Shah BD; Stock W
    Blood Cancer Discov; 2024 May; 5(3):164-179. PubMed ID: 38150184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TP53 mutation does not confer a poor outcome in adult patients with acute lymphoblastic leukemia who are treated with frontline hyper-CVAD-based regimens.
    Kanagal-Shamanna R; Jain P; Takahashi K; Short NJ; Tang G; Issa GC; Ravandi F; Garcia-Manero G; Yin CC; Luthra R; Patel KP; Khoury JD; Montalban-Bravo G; Sasaki K; Kadia TM; Borthakur G; Konopleva M; Jain N; Garris R; Pierce S; Wierda W; Estrov Z; Cortes J; O'Brien S; Kantarjian HM; Jabbour E
    Cancer; 2017 Oct; 123(19):3717-3724. PubMed ID: 28608976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The genomic landscape of hypodiploid acute lymphoblastic leukemia.
    Holmfeldt L; Wei L; Diaz-Flores E; Walsh M; Zhang J; Ding L; Payne-Turner D; Churchman M; Andersson A; Chen SC; McCastlain K; Becksfort J; Ma J; Wu G; Patel SN; Heatley SL; Phillips LA; Song G; Easton J; Parker M; Chen X; Rusch M; Boggs K; Vadodaria B; Hedlund E; Drenberg C; Baker S; Pei D; Cheng C; Huether R; Lu C; Fulton RS; Fulton LL; Tabib Y; Dooling DJ; Ochoa K; Minden M; Lewis ID; To LB; Marlton P; Roberts AW; Raca G; Stock W; Neale G; Drexler HG; Dickins RA; Ellison DW; Shurtleff SA; Pui CH; Ribeiro RC; Devidas M; Carroll AJ; Heerema NA; Wood B; Borowitz MJ; Gastier-Foster JM; Raimondi SC; Mardis ER; Wilson RK; Downing JR; Hunger SP; Loh ML; Mullighan CG
    Nat Genet; 2013 Mar; 45(3):242-52. PubMed ID: 23334668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Age-specific induction of mutant p53 drives clonal hematopoiesis and acute myeloid leukemia in adult mice.
    Pourebrahim R; Montoya RH; Akiyama H; Ostermann L; Khazaei S; Muftuoglu M; Baran N; Zhao R; Lesluyes T; Liu B; Khoury JD; Gagea M; Van Loo P; Andreeff M
    Cell Rep Med; 2024 May; 5(5):101558. PubMed ID: 38733986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adult Low-Hypodiploid Acute B-Lymphoblastic Leukemia With IKZF3 Deletion and TP53 Mutation: Comparison With Pediatric Patients.
    Fang M; Becker PS; Linenberger M; Eaton KD; Appelbaum FR; Dreyer Z; Airewele G; Redell M; Lopez-Terrada D; Patel A; Rabin KR; Lu X
    Am J Clin Pathol; 2015 Aug; 144(2):263-70. PubMed ID: 26185311
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic targeting of mutant p53 in pediatric acute lymphoblastic leukemia.
    Demir S; Boldrin E; Sun Q; Hampp S; Tausch E; Eckert C; Ebinger M; Handgretinger R; Kronnie GT; Wiesmüller L; Stilgenbauer S; Selivanova G; Debatin KM; Meyer LH
    Haematologica; 2020 Jan; 105(1):170-181. PubMed ID: 31073076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic and epigenetic characterization of hypodiploid acute lymphoblastic leukemia.
    Safavi S; Olsson L; Biloglav A; Veerla S; Blendberg M; Tayebwa J; Behrendtz M; Castor A; Hansson M; Johansson B; Paulsson K
    Oncotarget; 2015 Dec; 6(40):42793-802. PubMed ID: 26544893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinct genetic pathways define pre-malignant versus compensatory clonal hematopoiesis in Shwachman-Diamond syndrome.
    Kennedy AL; Myers KC; Bowman J; Gibson CJ; Camarda ND; Furutani E; Muscato GM; Klein RH; Ballotti K; Liu S; Harris CE; Galvin A; Malsch M; Dale D; Gansner JM; Nakano TA; Bertuch A; Vlachos A; Lipton JM; Castillo P; Connelly J; Churpek J; Edwards JR; Hijiya N; Ho RH; Hofmann I; Huang JN; Keel S; Lamble A; Lau BW; Norkin M; Stieglitz E; Stock W; Walkovich K; Boettcher S; Brendel C; Fleming MD; Davies SM; Weller EA; Bahl C; Carter SL; Shimamura A; Lindsley RC
    Nat Commun; 2021 Feb; 12(1):1334. PubMed ID: 33637765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TP53 mutations are frequent in adult acute lymphoblastic leukemia cases negative for recurrent fusion genes and correlate with poor response to induction therapy.
    Chiaretti S; Brugnoletti F; Tavolaro S; Bonina S; Paoloni F; Marinelli M; Patten N; Bonifacio M; Kropp MG; Sica S; Guarini A; Foà R
    Haematologica; 2013 May; 98(5):e59-61. PubMed ID: 23403321
    [No Abstract]   [Full Text] [Related]  

  • 14. Mutations and deletions of the TP53 gene predict nonresponse to treatment and poor outcome in first relapse of childhood acute lymphoblastic leukemia.
    Hof J; Krentz S; van Schewick C; Körner G; Shalapour S; Rhein P; Karawajew L; Ludwig WD; Seeger K; Henze G; von Stackelberg A; Hagemeier C; Eckert C; Kirschner-Schwabe R
    J Clin Oncol; 2011 Aug; 29(23):3185-93. PubMed ID: 21747090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p53 involvement in clonal hematopoiesis of indeterminate potential.
    Chen S; Liu Y
    Curr Opin Hematol; 2019 Jul; 26(4):235-240. PubMed ID: 31045645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MYC Expression Is Associated With p53 Expression and TP53 Aberration and Predicts Poor Overall Survival in Acute Lymphoblastic Leukemia/Lymphoma.
    Gao L; Harbaugh B; Parr K; Patel P; Golem S; Zhang D; Woodroof J; Cui W
    Am J Clin Pathol; 2022 Jan; 157(1):119-129. PubMed ID: 34528662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutations in TP53 and JAK2 are independent prognostic biomarkers in B-cell precursor acute lymphoblastic leukaemia.
    Forero-Castro M; Robledo C; Benito R; Bodega-Mayor I; Rapado I; Hernández-Sánchez M; Abáigar M; Maria Hernández-Sánchez J; Quijada-Álamo M; María Sánchez-Pina J; Sala-Valdés M; Araujo-Silva F; Kohlmann A; Luis Fuster J; Arefi M; de Las Heras N; Riesco S; Rodríguez JN; Hermosín L; Ribera J; Camos Guijosa M; Ramírez M; de Heredia Rubio CD; Barragán E; Martínez J; Ribera JM; Fernández-Ruiz E; Hernández-Rivas JM
    Br J Cancer; 2017 Jul; 117(2):256-265. PubMed ID: 28557976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Somatic TP53 mutations are preleukemic events in acute lymphoblastic leukemia.
    Chitadze G; Stengel A; John-Klaua C; Bruckmüller J; Trautmann H; Kotrova M; Darzentas F; Kelm M; Pal K; Darzentas N; Bastian L; Kehden B; Wessels W; Ströh AS; Oberg HH; Altrock PM; Baer C; Meggendorfer M; Gökbuget N; Baldus CD; Haferlach C; Brüggemann M
    Blood; 2023 Mar; 141(13):1640-1644. PubMed ID: 36450137
    [No Abstract]   [Full Text] [Related]  

  • 19. TP53 alterations in relapsed childhood acute lymphoblastic leukemia.
    Yu CH; Chang WT; Jou ST; Lin TK; Chang YH; Lin CY; Lin KH; Lu MY; Chen SH; Wu KH; Wang SC; Chang HH; Su YN; Hung CC; Lin DT; Chen HY; Yang YL
    Cancer Sci; 2020 Jan; 111(1):229-238. PubMed ID: 31729120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutational analysis of TP53 gene in Tunisian familial hematological malignancies and sporadic acute leukemia cases.
    Hamadou WS; Besbes S; Bourdon V; Youssef YB; Laatiri MA; Noguchi T; Khélif A; Sobol H; Soua Z
    Fam Cancer; 2017 Jan; 16(1):153-157. PubMed ID: 27619989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.